Results 231 to 240 of about 4,423,584 (309)

Prevalence and Risk Factors for Bladder and Bowel Dysfunction in Children With Type 1 Diabetes. [PDF]

Pediatr Diabetes
Favel K, Kelly MS, Lam STT, Bone JN, Morgan KE, Stephany HA, Thomas S, Afshar K, Panagiotopoulos C.   +8 more
europepmc   +1 more source

S100A1 and S100B Expression and Target Proteins in Type I Diabetes¹

, 1997
Danna B. Zimmer, Julie Chessher, Glenn L. Wilson, Warren E. Zimmer   +3 more
openalex   +1 more source

Cytokine Engineering Approaches for Regenerative Medicine

Advanced Therapeutics, EarlyView.
Engineered cytokines represent a powerful strategy to promote tissue repair and regeneration by precisely modulating immune responses. This review highlights recent advances in cytokine engineering, including strategies to enhance half‐life, improve tissue and cell targeting, and control receptor signaling.
Shiyi Li, Wenhao You, Mikaël M. Martino
wiley   +1 more source

Editorial: Disease-modifying approaches in type 1 diabetes. [PDF]

Front Endocrinol (Lausanne)
Nwosu BU, Pappachan JM, Ashraf AP.
europepmc   +1 more source

Genetic Engineering Methods in Primary T Cells

Advanced Therapeutics, EarlyView.
Primary T cells can be engineered to confer them with novel therapeutic functions, allowing them to treat a variety of conditions. Genetic engineering can be either stable or transient, aiming to either express or inhibit a target gene. This review discusses the various genetic engineering tools available as well as their characteristics and ...
Anthony Youssef, Hui‐Shan Li
wiley   +1 more source

Update on slowly progressive type 1 diabetes. [PDF]

J Diabetes Investig
Oikawa Y, Haisa A, Satomura A, Shimada A.   +3 more
europepmc   +1 more source

Evolution of Ocular Organ‐On‐Chip Systems for Disease Modelling and Drug Testing: Where are We Now?

Advanced Therapeutics, EarlyView.
The rise in ophthalmic diseases due to aging, screen use, and environmental factors has driven demand for better ocular models. Traditional systems fall short, encouraging the development of organ‐on‐chip devices. These microfluidic platforms replicate eye tissue architecture, enable drug screening, and simulate ocular diseases.
Sara Trujillo
wiley   +1 more source

Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review.

JMIR Res Protoc
Rollet M, Aguayo GA, Riveline JP, Cosson E, Fagherazzi G.   +4 more
europepmc   +1 more source

Epicardial adipose tissue in type 1 diabetes mellitus: a systematic review and meta-analysis. [PDF]

Egypt Heart J
Sooragonda BG, Karnwal V, Gunaseelan V, Joshi A, Biswas K, Shenoy MT, Anbazhagan R.   +6 more
europepmc   +1 more source